MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study

Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim wa...

Full description

Bibliographic Details
Main Authors: Amna Yasmin, Asla Pitkänen, Kimmo Jokivarsi, Pekka Poutiainen, Olli Gröhn, Riikka Immonen
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Neuroscience
Subjects:
GSH
Ins
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00863/full
id doaj-d0d4ede9c10c4f9d8850be7875e3e27c
record_format Article
spelling doaj-d0d4ede9c10c4f9d8850be7875e3e27c2020-11-24T21:27:00ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-08-011310.3389/fnins.2019.00863471104MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up StudyAmna Yasmin0Asla Pitkänen1Kimmo Jokivarsi2Pekka Poutiainen3Olli Gröhn4Riikka Immonen5A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, FinlandCenter of Diagnostic Imaging, Department of Cyclotron and Radiopharmacy, Kuopio University Hospital, Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, FinlandSustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim was to characterize the evolution of chronic inflammation during lesion expansion in lateral fluid-percussion injury (FPI) rat model with focus on the MRI-negative perilesional cortex. T2-weighted MR imaging (T2w MRI) and localized magnetic resonance spectroscopy (MRS) were performed at 1, 3, and 6 months post-injury. End-point histology, including Nissl for neuronal death, GFAP for astrogliosis, and Prussian Blue for iron were used to assess perilesional histopathology. An additional animal cohort was imaged with a positron emission tomography (PET) using translocator protein 18 kDa (TSPO) radiotracer [18F]-FEPPA. T2w MRI assessed lesion growth and detected chronic inflammation along the lesion border while rest of the ipsilateral cortex was MRI-negative (MRI-). Instead, myo-inositol that is an inflammatory MRS marker for gliosis, glutathione for oxidative stress, and choline for membrane turnover were elevated throughout the 6-months follow-up in the MRI- perilesional cortex (all p < 0.05). MRS markers revealed chronically sustained inflammation across the ipsilateral cortex but did not indicate the upcoming lesion expansion. Instead, the rostral expansion of the cortical lesion was systematically preceded by a hyperintense band in T2w images months earlier. Histologic analysis of the hyperintensity indicated scattered astrocytes, incomplete glial scar, and intracellularly packed and free iron. Yet, the band was negative in [18F]-FEPPA-PET. [18F]-FEPPA also showed no cortical TSPO expression within the MRS voxel in MRI- perilesional cortex or anywhere along glial scar when assessed at 2 months post-injury. However, [18F]-FEPPA showed a robust signal increase, indicating reactive microgliosis in the ipsilateral thalamus at 2 months post-TBI. We present evidence that MRS reveals chronic posttraumatic inflammation in MRI-negative perilesional cortex. The mismatch in MRS, MRI, and PET measures may allow non-invasive endophenotyping of beneficial and detrimental inflammatory processes to aid targeting and timing of anti-inflammatory therapeutics.https://www.frontiersin.org/article/10.3389/fnins.2019.00863/fullantioxidantGPC+PChoGSHInsneurochemical profileneuroinflammation
collection DOAJ
language English
format Article
sources DOAJ
author Amna Yasmin
Asla Pitkänen
Kimmo Jokivarsi
Pekka Poutiainen
Olli Gröhn
Riikka Immonen
spellingShingle Amna Yasmin
Asla Pitkänen
Kimmo Jokivarsi
Pekka Poutiainen
Olli Gröhn
Riikka Immonen
MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
Frontiers in Neuroscience
antioxidant
GPC+PCho
GSH
Ins
neurochemical profile
neuroinflammation
author_facet Amna Yasmin
Asla Pitkänen
Kimmo Jokivarsi
Pekka Poutiainen
Olli Gröhn
Riikka Immonen
author_sort Amna Yasmin
title MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_short MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_full MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_fullStr MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_full_unstemmed MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_sort mrs reveals chronic inflammation in t2w mri-negative perilesional cortex – a 6-months multimodal imaging follow-up study
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2019-08-01
description Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim was to characterize the evolution of chronic inflammation during lesion expansion in lateral fluid-percussion injury (FPI) rat model with focus on the MRI-negative perilesional cortex. T2-weighted MR imaging (T2w MRI) and localized magnetic resonance spectroscopy (MRS) were performed at 1, 3, and 6 months post-injury. End-point histology, including Nissl for neuronal death, GFAP for astrogliosis, and Prussian Blue for iron were used to assess perilesional histopathology. An additional animal cohort was imaged with a positron emission tomography (PET) using translocator protein 18 kDa (TSPO) radiotracer [18F]-FEPPA. T2w MRI assessed lesion growth and detected chronic inflammation along the lesion border while rest of the ipsilateral cortex was MRI-negative (MRI-). Instead, myo-inositol that is an inflammatory MRS marker for gliosis, glutathione for oxidative stress, and choline for membrane turnover were elevated throughout the 6-months follow-up in the MRI- perilesional cortex (all p < 0.05). MRS markers revealed chronically sustained inflammation across the ipsilateral cortex but did not indicate the upcoming lesion expansion. Instead, the rostral expansion of the cortical lesion was systematically preceded by a hyperintense band in T2w images months earlier. Histologic analysis of the hyperintensity indicated scattered astrocytes, incomplete glial scar, and intracellularly packed and free iron. Yet, the band was negative in [18F]-FEPPA-PET. [18F]-FEPPA also showed no cortical TSPO expression within the MRS voxel in MRI- perilesional cortex or anywhere along glial scar when assessed at 2 months post-injury. However, [18F]-FEPPA showed a robust signal increase, indicating reactive microgliosis in the ipsilateral thalamus at 2 months post-TBI. We present evidence that MRS reveals chronic posttraumatic inflammation in MRI-negative perilesional cortex. The mismatch in MRS, MRI, and PET measures may allow non-invasive endophenotyping of beneficial and detrimental inflammatory processes to aid targeting and timing of anti-inflammatory therapeutics.
topic antioxidant
GPC+PCho
GSH
Ins
neurochemical profile
neuroinflammation
url https://www.frontiersin.org/article/10.3389/fnins.2019.00863/full
work_keys_str_mv AT amnayasmin mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT aslapitkanen mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT kimmojokivarsi mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT pekkapoutiainen mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT olligrohn mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT riikkaimmonen mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
_version_ 1725977026927525888